Page last updated: 2024-08-18

chalcone and Bone Loss, Osteoclastic

chalcone has been researched along with Bone Loss, Osteoclastic in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Cirelli, G; de Assis, LR; de Godoi, MA; de Matos, IAF; Fernandes, NAR; GuimarĂ£es-Stabili, MR; Regasini, LO; Rossa Junior, C1
Camilli, AC; Fernandes, NAR; GuimarĂ£es-Stabili, MR; Maldonado, LAG; Molon, RS; Pacheco, CGP; Regasini, LO; Ribeiro de Assis, L; Rossa Junior, C; Silva, AF; Spolidorio, LC1
Jiang, J; Li, L; Liu, L; Pan, W; Tao, W; Yu, Q; Zhang, D1

Other Studies

3 other study(ies) available for chalcone and Bone Loss, Osteoclastic

ArticleYear
Chalcone T4 Inhibits RANKL-Induced Osteoclastogenesis and Stimulates Osteogenesis In Vitro.
    International journal of molecular sciences, 2023, Apr-21, Volume: 24, Issue:8

    Topics: Animals; Bone Resorption; Cell Differentiation; Chalcone; Chalcones; Core Binding Factor Alpha 1 Subunit; Matrix Metalloproteinase 9; Mice; NF-kappa B; NFATC Transcription Factors; Osteoclasts; Osteogenesis; Proto-Oncogene Proteins c-akt; RANK Ligand

2023
Chalcone T4, a novel chalconic compound, inhibits inflammatory bone resorption in vivo and suppresses osteoclastogenesis in vitro.
    Journal of periodontal research, 2021, Volume: 56, Issue:3

    Topics: Alveolar Bone Loss; Animals; Bone Resorption; Cell Differentiation; Chalcone; Chalcones; Mice; Osteoclasts; Osteogenesis; RANK Ligand; Rats

2021
Hydroxysafflor Yellow A Promoted Bone Mineralization and Inhibited Bone Resorption Which Reversed Glucocorticoids-Induced Osteoporosis.
    BioMed research international, 2018, Volume: 2018

    Topics: Animals; Bone and Bones; Bone Density; Bone Resorption; Calcification, Physiologic; Chalcone; Glucocorticoids; Humans; Osteoblasts; Osteoporosis; Quinones; Zebrafish

2018